2022
DOI: 10.21203/rs.3.rs-1825407/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

COVID-19 booster vaccine willingness among patients with chronic kidney disease in Taizhou, China

Abstract: Purpose: Investgate the willingness of CKD patients to receive a COVID-19 booster vaccine dose and analyze the related factors of COVID-19 booster vaccine willingness in such patients.Methods: An online questionnaire investigation addressing participants’ willingness to receive a booster dose of COVID-19 vaccine was organized among patients with chronic kidney disease in Taizhou, China.Result: A total of 350 valid copies were retrieved, among which 246 respondents (70.29%) were willing to receive a COVID-19 bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…In this study on COVID-19 booster vaccination willingness in patients with chronic kidney disease, it was discovered that, overall, 78.2% of respondents stated their intention to receive a COVID-19 vaccine booster, and 25.7% reported a definite intention. A recent study survey from China among 350 CKD patients showed that around 70.29% of the respondents reported their willingness to receive a COVID-19 booster vaccine dose [ 19 ]. When compared to a recent study conducted among patients with another chronic medical condition (inflammatory bowel disease) in Kuwait that reported only 58.1% acceptance, the willingness to receive a COVID-19 vaccination booster dose was higher in our study [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this study on COVID-19 booster vaccination willingness in patients with chronic kidney disease, it was discovered that, overall, 78.2% of respondents stated their intention to receive a COVID-19 vaccine booster, and 25.7% reported a definite intention. A recent study survey from China among 350 CKD patients showed that around 70.29% of the respondents reported their willingness to receive a COVID-19 booster vaccine dose [ 19 ]. When compared to a recent study conducted among patients with another chronic medical condition (inflammatory bowel disease) in Kuwait that reported only 58.1% acceptance, the willingness to receive a COVID-19 vaccination booster dose was higher in our study [ 22 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, few studies have examined CKD patients’ resistance to receiving the COVID-19 booster dose. Only 70.29% of research participants with CKD were willing to get a booster dose of the COVID-19 vaccination, according to a recent Chinese study [ 19 ].…”
Section: Introductionmentioning
confidence: 99%